CHA News

FDA Extends Shelf Life of Certain Intravenous Products

Manufacturer updates providers on product supply

This post has been archived and contains information that may be out of date.

Responding to hospitals’ concerns over the continuing shortage of certain intravenous solutions used in clinical care, the Food and Drug Administration yesterday announced that certain products manufactured by Baxter Healthcare Corporation may be used beyond their labeled expiration date. To help ensure patient safety, these products should continue to be stored as labeled. If replacement product becomes available during the extension period, hospitals are expected to replace and properly dispose of the products soon as possible. Health care professionals are instructed to squeeze the bags prior to use to verify they do not have leaks; if leaks are found, the bags should not be used.

This content is restricted to members.